Thomas Christopher Westbrook, Frank Cameron Cackowski, Joshi J. Alumkal, Anbarasu Kumaraswamy, Megan Veresh Caram, Sarah Elizabeth Yentz, Ulka N. Vaishampayan, Manjunath Pai, Thomas Braun, Zachery R Reichert. "Study of JAK inhibition in stem-like prostate cancer (JASPER): A phase 1/2 multicenter study of ruxolitinib and enzalutamide in castration resistant prostate cancer undergoing lineage plasticity.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps297